MedDataX Logo

Radiographic Changes and Clinical Implications of Implantation of Shortened Uncemented Femoral Stems in THA

NCT ID: NCT05666284

Last Updated: 2023-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

204 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-11

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hip prosthesis market is constantly growing with the number of prostheses reaching 949,000 in 2019. Along with this, there is also an increase in interest in short stems also called shortened stems. Thus on Pubmed, in 5 years, 171 publications have been listed.

Thus, it seems interesting to study and analyze the performance of the shortened stem used in the Department of Orthopedic Surgery and Traumatology of the University Hospitals of Strasbourg and to compare them with the results of the literature.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of this study is to observe the appearance of shortened stem radiological abnormalities at least 2 years postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aseptic; Osteonecrosis Hip Osteoarthritis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Hip Osteoarthritis Aseptic; Osteonecrosis Coxarthrosis Avascular Necrosis of the Femoral Head

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female (age ≥18 years old)
* Subject operated for first-line THA for an indication of centric hip osteoarthritis (including minor dysplasia and coxa profunda) and aseptic osteonecrosis of the femoral head
* Subject who received a THA between January 2015 and December 2019
* Subject who received an uncemented shortened SCC or SCLA femoral stem
* Radiological data available: pre-operative, immediate post-operative and post-operative at a minimum of 2 years (≥24 months)
* Subject not objecting to the reuse of their data for scientific research purposes.

Exclusion Criteria

* Subject having expressed its opposition to the reuse of its data for scientific research purposes.
* Patient operated for inflammatory pathology or major dysplasia, recovery
* Associated fractures or sequelae of fractures
* Patient having presented intraoperative or early complications such as infections, intraoperative fracture, dislocation of the hip following the installation of the THA
* Revision of hip arthroplasty during the study follow-up period for a cause not studied in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Chirurgie Orthopédique et de Traumatologie du Membre Inférieur - CHU de Strasbourg - France

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

François BONNOMET, MD, PhD

Role: CONTACT

Phone: 33 3 68 76 52 82

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

François BONNOMET, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8720

Identifier Type: -

Identifier Source: org_study_id